Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1258854.RA4D9_2OD13zWd1CjDk3gIQeqkNuQPGJZA2OaiLOYTArs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1258854.RA4D9_2OD13zWd1CjDk3gIQeqkNuQPGJZA2OaiLOYTArs130_assertion type Assertion NP1258854.RA4D9_2OD13zWd1CjDk3gIQeqkNuQPGJZA2OaiLOYTArs130_head.
- NP1258854.RA4D9_2OD13zWd1CjDk3gIQeqkNuQPGJZA2OaiLOYTArs130_assertion description "[In conclusion, the results of the present study demonstrated that Pdcd5 increased the chemosensitivity of prostate cancer cells and decreased the toxicity of cisplatin via activation of the receptor?associated apoptotic pathway; this may therefore indicate the combined use of cisplatin and Pdcd5 as a novel therapeutic strategy for the treatment of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258854.RA4D9_2OD13zWd1CjDk3gIQeqkNuQPGJZA2OaiLOYTArs130_provenance.
- NP1258854.RA4D9_2OD13zWd1CjDk3gIQeqkNuQPGJZA2OaiLOYTArs130_assertion evidence source_evidence_literature NP1258854.RA4D9_2OD13zWd1CjDk3gIQeqkNuQPGJZA2OaiLOYTArs130_provenance.
- NP1258854.RA4D9_2OD13zWd1CjDk3gIQeqkNuQPGJZA2OaiLOYTArs130_assertion SIO_000772 25625867 NP1258854.RA4D9_2OD13zWd1CjDk3gIQeqkNuQPGJZA2OaiLOYTArs130_provenance.
- NP1258854.RA4D9_2OD13zWd1CjDk3gIQeqkNuQPGJZA2OaiLOYTArs130_assertion wasDerivedFrom befree-2016 NP1258854.RA4D9_2OD13zWd1CjDk3gIQeqkNuQPGJZA2OaiLOYTArs130_provenance.
- NP1258854.RA4D9_2OD13zWd1CjDk3gIQeqkNuQPGJZA2OaiLOYTArs130_assertion wasGeneratedBy ECO_0000203 NP1258854.RA4D9_2OD13zWd1CjDk3gIQeqkNuQPGJZA2OaiLOYTArs130_provenance.